LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
OECD SIDS <strong>LINEAR</strong> <strong>ALKYLBENZENE</strong> <strong>SULFONATE</strong> (<strong>LAS</strong>)<br />
for physical and behavioral signs of toxicity. Analysis of blood,<br />
biochemistry and urine were conducted. Monkeys were held in individual<br />
wall-mounted cages at a room temperature of 22 + /-1 o C and normal daylight.<br />
Food consisted of 300 g dry diet and bread daily, and fresh fruit on alternate<br />
days. Tap water for drinking was freely available.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
Test substance: C10-13 <strong>LAS</strong>, activity: 20.5%<br />
Remarks: The SDA/NOTOX report sets a systemic NOAEL of 30 mg/kg/day (oral)<br />
with 0.1 mg/kg/day (sc). However, based on the information provided in the<br />
article and reiterated above, the actual systemic NOAEL is considered to be<br />
150 mg/kg/day (oral) with 0.5 mg/kg/day (sc). According to the authors, the<br />
three combined doses correspond to 100, 500 and 1000 times the estimated<br />
maximum human daily intake.<br />
Reference: Heywood, R., James, R.W., and Sortwell, R.J. 1978. Toxicology studies of<br />
linear alkylbenzene sulphonate (<strong>LAS</strong>) in rhesus monkeys. I. Simultaneous<br />
oral and subcutaneous administration for 28 days. Toxicology 11:245-250.<br />
Reliability: 2 Valid with restrictions<br />
(n)<br />
Species/strain: Rat (Wistar)<br />
Sex: Female [ ]; Male [X]; Male/Female [ ]; No data [ ]<br />
Administration: Dermal<br />
Exposure period: 15 days<br />
Frequency of treatment: daily<br />
Dose: 0.5 g applied 20 and 30% <strong>LAS</strong> solutions (about 286 and 427 mg/kg bw d)<br />
Control group: Yes [ ]; No [ ]; No data [ ];<br />
Concurrent no treatment [ ]; Concurrent vehicle [ ]; Historical [ ]<br />
LOAEL: 20% (286 mg/kg bw d) (lowest dose tested)<br />
Results: Body weight gain was suppressed in the 20% group and the body weight was<br />
decreased in the 30% group. An infiltrating, yellowish-reddish brown crust<br />
was observed 2-3 days in the 20% group, and at 1-2 days in the 30% group.<br />
At 4-6 days the crust was abraded and erosion occurred at the abraded site.<br />
Histological examinations of the application site revealed severe necrosis of<br />
the region from the epidermis cuticle to the upper layer of the dermis, severe<br />
infiltration of leukocytes in the necrotic site, diffuse inflammatory cell<br />
infiltration of all layers of the corium. No changes were observed in the<br />
tongue, but the oral mucosa revealed atrophy and slight degeneration of the<br />
epithelium. No systemic effects were observed.<br />
Method: <strong>LAS</strong> was applied to the backs of the rats. On the 16 th day of the experiment,<br />
skin at the application site and the tissues of the tongue and oral mucosa (to<br />
examine the effects of licking) of the rats that received 30% were examined<br />
histologically.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
Test substance: <strong>LAS</strong>, activity: 99.9%<br />
Remarks: Information as cited in the IPCS document. Because of necrosis at the<br />
application site, it is not possible to know exactly how much <strong>LAS</strong> was<br />
absorbed. Effects were probably due to local effects, so the results are best<br />
described as a local LOAEL.<br />
Reference: 1) European Commission. 2000a. Benzenesulfonic acid, C10-13-alkyl derivs.,<br />
sodium salts. Year 2000 CD-ROM edition.<br />
2) Sadai, M. and Mizuno, N. 1972. Effect of long term topical application of<br />
some anionic surfactants on the skin, oral mucous membrane, and tongue.<br />
Jpn Journal Dermatol. 82:207-221. (in Japanese); cited in: IPCS (1996);<br />
Environmental Health Criteria 169: Linear Alkylbenzene Sulfonates (<strong>LAS</strong>)<br />
and Related Compounds. WHO, Geneva, Switzerland.<br />
<strong>UNEP</strong> PUBLICATIONS 279